Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 12;188(12):3329-3348.e31.
doi: 10.1016/j.cell.2025.03.037. Epub 2025 Apr 17.

Fate and state transitions during human blood vessel organoid development

Affiliations
Free article

Fate and state transitions during human blood vessel organoid development

Marina T Nikolova et al. Cell. .
Free article

Abstract

Human blood vessel organoids (hBVOs) have emerged as a system to model human vascular development and disease. Here, we use single-cell multi-omics together with genetic and signaling pathway perturbations to reconstruct hBVO development. Mesodermal progenitors bifurcate into endothelial and mural fates in vitro, and xenografted BVOs acquire definitive arteriovenous endothelial cell specification. We infer a gene regulatory network and use single-cell genetic perturbations to identify transcription factors (TFs) and receptors involved in cell fate specification, including a role for MECOM in endothelial and mural specification. We assess the potential of BVOs to generate organotypic states, identify TFs lacking expression in hBVOs, and find that induced LEF1 overexpression increases brain vasculature specificity. Finally, we map vascular disease-associated genes to hBVO cell states and analyze an hBVO model of diabetes. Altogether, we provide a comprehensive cell state atlas of hBVO development and illuminate the power and limitation of hBVOs for translational research.

Keywords: arteriovenous specification; human blood vessel organoid; human development; organoid cell atlas; single-cell genomics; single-cell perturbation screen.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests J.M.P. is one of the authors of the patent application US20200199541A1 relating to blood vessel organoid generation. Furthermore, J.M.P. is the founder, shareholder, and chairman of the scientific advisory board of Angios Biotech, a company establishing BVOs for drug testing and vascular transplants.

Substances

LinkOut - more resources